MDS Sciex Revenues Slip 4 Percent in Fiscal Q1 as Earnings Slide

MDS Sciex this week reported that instrument sales during its fiscal first quarter declined 4 percent to $71 million from $74 million for the year-ago period.

Profits for MDS Sciex also fell to $19 million from $21 million in the first quarter of 2005, a 9.5-percent decline. The company said the decrease was "principally due to currency."

MDS said that the best-selling products in its Sciex unit were the API 5000, the 4800 MALDI/TOF/TOF, and the 3200 Qtrap.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.